 | | Raltegravir (Isentress) |  | | Published
November 13, 2007; Updated
October 19, 2011 | Susa Coffey, MD
http://hivinsite.ucsf.edu/InSite?page=ar-07-01 | | | Selected Reference | | 4. | Anderson MS, Kakuda TN, Miller JL, et al. Pharmacokinetic evaluation of non-nucleoside reverse transcriptase inhibitor (NNRTI) TMC125 and integrase inhibitor (InSTI) raltegravir (RAL) in healthy subjects. In: Program and abstract of the 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention; July 22-25, 2007; Sydney, Australia. Abstract TUPDB02 | |
|
|
|
